Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression

- Heng, Benjamin, Bilgin, Ayse A., Guillemin, Gilles J., Lovejoy, David B., Tan, Vanessa X., Milioli, Heloisa H., Gluch, Laurence, Bustamante, Sonia, Sabaretnam, Tharani, Moscato, Pablo, Lim, Chai K.

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

- Jézéquel, Pascal, Kerdraon, Olivier, Hondermarck, Hubert, Guerin-Charbonnel, Catherine, Lasla, Hamza, Gouraud, Wilfried, Canon, Jean-Luc, Gombos, Andrea, Dalenc, Florence, Delaloge, Suzette, Lemonnier, Jérôme, Loussouarn, Delphine, Verrièle, Véronique, Campone, Mario

Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients

- Chatterjee, Gaurav, Pai, Trupti, Hardiman, Thomas, Avery-Kiejda, Kelly, Scott, Rodney J., Spencer, Jo, Pinder, Sarah E., Grigoriadis, Anita

Impact of CYO19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

- Johansson, Harriet, Gray, Kathryn P., Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A., TEXT principal investigators,, Pagani, Olivia, Chirgwin, Jaqueline, Francis, Prudence, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

- Thompson, Ella R., Gorringe, Kylie L., Lupat, Richard, Delatycki, Martin B., LifePool Investigators,, Mitchell , Gillian, James , Paul A., Scott, Rodney J., Campbell, Ian G., Rowley, Simone M., Wong-Brown, Michelle W., McInerny, Simone, Li, Na, Trainer, Alison H., Devereux, Lisa, Doyle, Maria A., Li, Jason